Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs

Topics: Drug Sources, Drug Benefit Assessment, Congeneric Drugs, Drug Administration, Oral Dosage Forms, dermatological agents, drug distribution, Drug Action, membrance permeation, drug transporters, drug elimination, drug metabolism, enteroheptaic circulation, presystemic elimination, pharmacokinetics, druig concentration, accumulation, dose-response relationship, drug-receptor interaction, agonists-antagonists, enantioselectivity, G-protein-couples receptors, plasma concentration, adverse drug effects, drug allergy, cutaenous reactions, pregnancy, lactation, drug-independent effects, cutaneous reaction, placebo theraphy, systems pharmacology, sympathetic system, cathecholamine actions, sympathomimetics, indirect sympathomimetics, Parasympathetic Nervous System, Parasympathetic Functions, Cholinergic Synapse, Parasympathomimetics, Parasympatholytics, biogenic agents, dopamine, histamine, serotonin, amino acids, vasodilators, organic nitrates, calcium antagonists, Renin-Angiotensin-Aldosterone System, ACE Inhibitors, smooth muscle, cardiac Drugs, Cardiac Glycosides, antiarrhythmic drugs, antianemic agents, anemias, iron compounds, antithrombotic agents, thrombosis therapy, Vitamin K, Heparin, fibrinolytics, platelet aggregation, plasma volume expanders, hyperlipoproteinemias, lipid-lowering agents, diuretics, water reabsorption, vasopressin, water and electrolyte disorders, Gastrointestinal Tract, Hyperacidity, antidiarrheal agents, motor system, muscle relaxants, nociceptors, pain, analgesics, eicosanoids, antipyretic analgesics, local anesthetics, opioids, General Anesthesia and General Anesthetic Drugs.lnhalational Anesthetics, Injectable Anesthetics, Anxiolytics, benzodiazepines, depressive illness, manic state, schizophrenia, endocrine system, hypothalamic hormone, hypophyseal hormone, thyroid hormone therapy, hyperthroidism, antithyroid drugs, glucocorticoid therapy, androgen, anabolic steroid, antiandrogen, follicular growth, ovulation, antibacterial drugs, antifungal drugs, antiviral drugs, antiparasitic drugs, tropical diseases, anticancer drugs, immune modulators

Topics: Haemostatic mechanism, blood vessels, superficial bleeding, petechiae, ecchymosis, non thrombocytopenic purpura, senile purpura, Hereditary haemorrhagic telangiectasia, Osler-Rendu-Weber syndrome, CONNECTIVE TISSUE DISORDERS, Ehlers-Danlos syndrome, Pseudoxanthoma elasticum, Osteogenesis imperfecta, Marfan’s syndrome, ALLERGIC PURPURA, Henoch-Schoenlin purpura, PSYCHOGENIC PURPURA, INFECTIOUS PURPURA, PLATELET ADHESSION, thrombocytopathies, Bernard-Soulier syndrome, Platelet type von-Willibrand, Montreal platelet syndrome, IMMUNE MEDIATED THRONBOCYTOPENIA, Auto Immune Thrombocytopenia, BONE MARROW SUPPRESSION, Thrombotic thrombocytopenic purpura, Haemolytic uraemic syndrome

Topics: blood components, Red cell concentrate, Washed Red cells, Frozen red cells, Platelet concentrates, Platelet, Platelet transfusion, Cryoprecipitate, Granulocyte transfusion, Blood Transfusion

Topics: PLASMA DERIVATIVES, Whole Blood, Red cell concentrate, RED CELL PRESERVATION, Saline-adenine-glucose- mannitol, RBC Types, Leukocyte-Reduced RBCs, Frozen RBCs, Deglycerolized RBCs, Washed RBCs, Irradiated RBCs, Platelet concentrate, Pooled platelets, platelet pheresis, Fresh Frozen Plasma, Pathogen- reduced plasma components, Methylene blue treated FFP, Solvent- detergent treated plasma, Cryoprecipitate, Granulocytes, Plasma derivatives, albumin, Immunoglobulins

Topics: Governance, Globalization, Political Systems, System, Process, Policy, Politics, Interest Articulation, Interest Aggregation, Countries, Culture, Government, Socialization, Citizen, Civil Society, Interest Groups, Geography, Constitutions, Decision Rules, Leadership, Political Participation

Topics: red blood cell transfusion, Transfusion threshold, Platelet transfusion, platelet, Granulocyte transfusion, Donor selection, blood donors, Donor screening

Topics: Vessel wall, Blood flow, coagulation substances, Hemostasis, Platelets, Platelet secretion, Clotting factors, clotting pathways, Dissolution of clots, Anticoagulants, PATHOPHYSIOLOGY

Topics: Blood Composition, Plasma makeup, Plasma, Albumins, Globulins, Clotting proteins, Red Blood Cells, White Blood Cells, Platelets, Blood Coagulation, Blood Clotting, Vascular spasm, Vasoconstriction, Platelet Plug, Fibrin, ABO Group System, Capillaries, Veins, Venules, Heart

Topics: Haemopoiesis, anaemia, Erythropoiesis, Hypochromic anaemia, iron oveload, Megaloblastic anaemia, macrocytic anaemia, Haemolytic anaemia, granulocytes, monocytes, lymphocytes, spleen, haematological malignancy, Acute myeloid leukaemia, Chronic myeloid leukaemia, Myeloproliferative disease, myeloid leukaemia, Myelodysplasia, chronic lymphoid leukaemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, Multiple myeloma, Aplastic anaemia, bone marrow failure, Stem cell transplantation, Platelets, blood coagulation, haemostasis, Bleeding disorders, platelet abnormalities, vascular abnormalities, Coagulation disorders, Thrombosis, Blood transfusion, Pregnancy haematology, neonatal haematology